Many large pharmaceutical companies are taking steps to improve access to their medicines in low- and middle-income countries, but progress has been mixed.
Many large pharmaceutical companies are taking steps to improve access to their medicines in low- and middle-income countries, but progress has been mixed.
<iframe src="https://statesidedaily.com/embed/cluster/0855d293bd94d7f05a1d561433e6ada508cd7cb1" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Pharma is a ‘mixed bag’ when providing drug access to low- and middle-income countries, analysis finds"></iframe>
